Owner Sankyo Company, Limited

Inventors Kohama, Takafumi; Kono, Keita; Sugiura, Masako

Agent Davies Collison Cave

Pub. Number AU-B-2001262734

PCT Pub. Number WO01/96575

Priority 2000-178039 14.06.00 JP

Filing date 11 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 30 September 2004

C12N 015/54 Mutation or genetic engineering - Transferases (2)

A61P 003/10 Drugs for disorders of the metabolism

A61P 003/04 Drugs for disorders of the metabolism

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 031/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

C07K 016/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12Q 001/48 Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 009/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

A61P 035/00 Antineoplastic agents

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 025/00 Drugs for disorders of the nervous system

A61P 007/00 Drugs for disorders of the blood or the extracellular fluid